Vitamin B1 Prices in China Rise 1.9% in November, Stabilize in Early December Amid Steady Demand

Vitamin B1 Prices in China Rise 1.9% in November, Stabilize in Early December Amid Steady Demand

Thomas Mann 15-Dec-2025

The Chinese Vitamin B1 market saw a significant jump in November, only to level out in the first week of December. Behind that upward tick was some robust overseas demand, plus a bit of an uptick in production costs, while inspections and scheduled maintenance did their part to tighten up supply. Export orders were holding steady in key markets like the United States, Brazil, and Europe - and that was a big help to the market - and logistics were calm, which let price adjustments go through. Demand in the domestic compound feed and nutraceutical sectors stayed healthy & buyers from overseas were busy restocking ahead of the year-end. Even though supply issues were a bit of an issue, the fact that there were good inventory levels on hand meant that buyers did not run for restocking. Then at the start of December trading, it looked like buyers were taking a more cautious approach. Word from the experts is that Vitamin B1 prices are due to take a bit of a hit in the coming weeks as the year-end demand starts to fade, export bookings slow a bit, and with all the inventories they already have on hand, the overall mood in the market is looking a bit bearish.

Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
Tags:

Vitamin B1

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.